Delivery Order SPE2DB22D1106-SPE2DB25FDZC8
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of APRETUDE ER 600 MG/3 ML VIAL 3ML. The contract has a ceiling value of $2,400.24 and an ultimate completion date of September 4, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of APRETUDE ER 600 MG/3 ML VIAL 3ML, a pharmaceutical product, with a ceiling value of $7,200.75 and a completion date of May 9, 2024. The contract was awarded on a full and open competition basis without any set-aside designation. As a major distributor of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,388.96 to AmerisourceBergen Drug Corp for the supply of Apretude ER 600 mg/3 mL vials on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 2, 2026, for the supply of Apretude ER 600 mg/3 mL vials. The contract is a firm fixed-price delivery order valued at $4,947.64 with an ultimate completion date of February 24, 2026. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This award was issued without a set-aside designation, indicating the procurement was conducted through full and open...
- On January 29, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $9,895.28 to AmerisourceBergen Drug Corp for Apretude ER 600 mg/3 mL vials. This firm fixed-price delivery order is scheduled for completion by February 20, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,164.36 and a performance period through May 9, 2025. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, and pain management. The contract is not...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $42,920.32 and is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 8, 2025. The contract was not set aside for any...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, has a ceiling value of $29,247.48 and a completion date of June 17, 2025. AmerisourceBergen Drug Corp is providing a range of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,373.24 and a period of performance through March 7, 2025. It is a firm fixed-price contract for the procurement of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $37,140.48 and an ultimate completion date of February 4, 2025. It is a Firm Fixed Price contract for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FDZC8Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,388.96 and is for the delivery of APRETUDE ER 600 MG/3 ML VIAL 3ML, a specialty pharmaceutical product. The contract is a firm fixed-price Delivery Order with a completion date of March 7, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 2/13/25 |